ID   SERA_RAT                Reviewed;         533 AA.
AC   O08651; Q546Q9;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   29-MAY-2024, entry version 173.
DE   RecName: Full=D-3-phosphoglycerate dehydrogenase;
DE            Short=3-PGDH;
DE            EC=1.1.1.95 {ECO:0000269|PubMed:9163325};
GN   Name=Phgdh;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBUNIT, TISSUE SPECIFICITY, FUNCTION,
RP   CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=9163325; DOI=10.1042/bj3230365;
RA   Achouri Y., Rider M.H., van Schaftingen E., Robbi M.;
RT   "Cloning, sequencing and expression of rat liver 3-phosphoglycerate
RT   dehydrogenase.";
RL   Biochem. J. 323:365-370(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Robbi M., Achouri Y., Szpirer C., Van Schaftingen E.;
RT   "Structure and chromosomal localization of the rat gene encoding 3-
RT   phosphoglycerate dehydrogenase.";
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 34-54; 248-270; 271-289 AND 365-380, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Spinal cord;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (NOV-2006) to UniProtKB.
CC   -!- FUNCTION: Catalyzes the reversible oxidation of 3-phospho-D-glycerate
CC       to 3-phosphonooxypyruvate, the first step of the phosphorylated L-
CC       serine biosynthesis pathway. Does not catalyze the reversible oxidation
CC       of 2-hydroxyglutarate to 2-oxoglutarate and the reversible oxidation of
CC       (S)-malate to oxaloacetate. {ECO:0000269|PubMed:9163325}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2R)-3-phosphoglycerate + NAD(+) = 3-phosphooxypyruvate + H(+)
CC         + NADH; Xref=Rhea:RHEA:12641, ChEBI:CHEBI:15378, ChEBI:CHEBI:18110,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:58272; EC=1.1.1.95;
CC         Evidence={ECO:0000269|PubMed:9163325};
CC   -!- PATHWAY: Amino-acid biosynthesis; L-serine biosynthesis; L-serine from
CC       3-phospho-D-glycerate: step 1/3. {ECO:0000269|PubMed:9163325}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:9163325}.
CC   -!- TISSUE SPECIFICITY: Liver, kidney, brain, testis.
CC       {ECO:0000269|PubMed:9163325}.
CC   -!- SIMILARITY: Belongs to the D-isomer specific 2-hydroxyacid
CC       dehydrogenase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X97772; CAA66374.1; -; mRNA.
DR   EMBL; AJ271975; CAB89828.1; -; Genomic_DNA.
DR   EMBL; BC086327; AAH86327.1; -; mRNA.
DR   RefSeq; NP_113808.1; NM_031620.1.
DR   RefSeq; XP_006233072.1; XM_006233010.1.
DR   AlphaFoldDB; O08651; -.
DR   SMR; O08651; -.
DR   BioGRID; 248638; 2.
DR   IntAct; O08651; 2.
DR   MINT; O08651; -.
DR   STRING; 10116.ENSRNOP00000053019; -.
DR   GlyGen; O08651; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O08651; -.
DR   PhosphoSitePlus; O08651; -.
DR   SwissPalm; O08651; -.
DR   jPOST; O08651; -.
DR   PaxDb; 10116-ENSRNOP00000053019; -.
DR   GeneID; 58835; -.
DR   KEGG; rno:58835; -.
DR   UCSC; RGD:61987; rat.
DR   AGR; RGD:61987; -.
DR   CTD; 26227; -.
DR   RGD; 61987; Phgdh.
DR   VEuPathDB; HostDB:ENSRNOG00000019328; -.
DR   eggNOG; KOG0068; Eukaryota.
DR   HOGENOM; CLU_019796_8_1_1; -.
DR   InParanoid; O08651; -.
DR   OrthoDB; 6392at2759; -.
DR   PhylomeDB; O08651; -.
DR   TreeFam; TF314548; -.
DR   BioCyc; MetaCyc:MONOMER-10261; -.
DR   Reactome; R-RNO-977347; Serine biosynthesis.
DR   UniPathway; UPA00135; UER00196.
DR   PRO; PR:O08651; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000019328; Expressed in pancreas and 19 other cell types or tissues.
DR   GO; GO:0051287; F:NAD binding; IEA:InterPro.
DR   GO; GO:0004617; F:phosphoglycerate dehydrogenase activity; IDA:RGD.
DR   GO; GO:0070314; P:G1 to G0 transition; ISO:RGD.
DR   GO; GO:0009448; P:gamma-aminobutyric acid metabolic process; ISO:RGD.
DR   GO; GO:0021782; P:glial cell development; ISO:RGD.
DR   GO; GO:0006541; P:glutamine metabolic process; ISO:RGD.
DR   GO; GO:0006544; P:glycine metabolic process; ISO:RGD.
DR   GO; GO:0006564; P:L-serine biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0006563; P:L-serine metabolic process; ISO:RGD.
DR   GO; GO:0021915; P:neural tube development; ISO:RGD.
DR   GO; GO:0022008; P:neurogenesis; ISO:RGD.
DR   GO; GO:0031175; P:neuron projection development; ISO:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0009070; P:serine family amino acid biosynthetic process; TAS:RGD.
DR   GO; GO:0021510; P:spinal cord development; ISO:RGD.
DR   GO; GO:0019530; P:taurine metabolic process; ISO:RGD.
DR   GO; GO:0006566; P:threonine metabolic process; ISO:RGD.
DR   CDD; cd12173; PGDH_4; 1.
DR   Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 2.
DR   InterPro; IPR029009; ASB_dom_sf.
DR   InterPro; IPR006139; D-isomer_2_OHA_DH_cat_dom.
DR   InterPro; IPR029753; D-isomer_DH_CS.
DR   InterPro; IPR029752; D-isomer_DH_CS1.
DR   InterPro; IPR006140; D-isomer_DH_NAD-bd.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR006236; PGDH.
DR   InterPro; IPR045626; PGDH_ASB_dom.
DR   NCBIfam; TIGR01327; PGDH; 1.
DR   PANTHER; PTHR42938:SF22; D-3-PHOSPHOGLYCERATE DEHYDROGENASE; 1.
DR   PANTHER; PTHR42938; FORMATE DEHYDROGENASE 1; 1.
DR   Pfam; PF00389; 2-Hacid_dh; 1.
DR   Pfam; PF02826; 2-Hacid_dh_C; 1.
DR   Pfam; PF19304; PGDH_inter; 1.
DR   SUPFAM; SSF52283; Formate/glycerate dehydrogenase catalytic domain-like; 1.
DR   SUPFAM; SSF51735; NAD(P)-binding Rossmann-fold domains; 1.
DR   SUPFAM; SSF143548; Serine metabolism enzymes domain; 1.
DR   PROSITE; PS00065; D_2_HYDROXYACID_DH_1; 1.
DR   PROSITE; PS00670; D_2_HYDROXYACID_DH_2; 1.
DR   PROSITE; PS00671; D_2_HYDROXYACID_DH_3; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Amino-acid biosynthesis; Direct protein sequencing;
KW   Isopeptide bond; NAD; Oxidoreductase; Phosphoprotein; Reference proteome;
KW   Serine biosynthesis; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:O43175"
FT   CHAIN           2..533
FT                   /note="D-3-phosphoglycerate dehydrogenase"
FT                   /id="PRO_0000076016"
FT   ACT_SITE        236
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        265
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        283
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250"
FT   BINDING         78
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:O43175"
FT   BINDING         155..156
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:O43175"
FT   BINDING         175
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:O43175"
FT   BINDING         207
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:O43175"
FT   BINDING         234..236
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:O43175"
FT   BINDING         260
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:O43175"
FT   BINDING         283..286
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:O43175"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:O43175"
FT   MOD_RES         14
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O43175"
FT   MOD_RES         21
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q61753"
FT   MOD_RES         58
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61753"
FT   MOD_RES         78
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O43175"
FT   CROSSLNK        21
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O43175"
FT   CROSSLNK        21
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O43175"
SQ   SEQUENCE   533 AA;  56493 MW;  7273DAC3349E95EF CRC64;
     MAFANLRKIL ISDSLDPCCR KILQDGGLQV VEKQNLSKEE LIAELQDCEG LIVRSATKVT
     ADVINAAEKL QVVGRAGTGV DNVDLEAATR KGVLVMNTPN GNSLSAAELT CGMLMCLARQ
     IPQATASMKD GKWDRKKFMG TELNGKTLGI LGLGRIGREV AARMQAFGMK TVGYDPIISP
     EVAASFGVQQ LPLEEIWPLC DFITVHTPLL PSTTGLLNDS TFAQCKKGVR VVNCARGGIV
     DEGALLRALQ SGQCAGAALD VFTEEPPRDR ALVDHENVIS CPHLGASTKE AQSRCGEEIA
     VQFVDMVKGK SLTGVVNAQA LTSAFSPHTK PWIGLAEALG TLMHAWAGSP KGTIQVVTQG
     TSLKNAGTCL SPAVIVGLLR EASKQADVNL VNAKLLVKEA GLNVTTSHSP GVPGEQGIGE
     CLLTVALAGA PYQAVGLVQG TTPMLQMLNG AVFRPEVPLR RGQPLLLFRA QPSDPVMLPT
     MIGLLAEAGV QLLSYQTSKV SDGDTWHVMG LSSLLPSLDA WKQHVSEAFQ FCF
//
